IP Library › Granted Patent US 7,435,553
Granted Patent B2
US 7,435,553 · App. 11/434,403 · Granted Oct 14, 2008

Isolating cells expressing secreted proteins

Assignee: Regeneron Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,435,553
App. No.
11/434,403
Granted
Oct 14, 2008
Kind
B2
Abstract

A method of detecting and isolating cells that produce any secreted protein of interest (POI), comprising: a) constructing a cell line transiently or stably expressing a cell surface capture molecule, which binds the POI, by transfecting the cell line with a nucleic acid that encodes such cell surface capture molecule; b) transfecting said cell simultaneously or subsequently with a second nucleic acid that encodes a POI wherein such POI is secreted; c) detecting the surface-displayed POI by contacting the cells with a detection molecule, which binds the POI; and d) isolating cells based on the detection molecule.

Claims (30)

1. A method of detecting and isolating a cell that produces a secreted protein of interest, comprising:

(a) constructing a cell line transiently or stably expressing a cell surface capture molecule that binds a protein of interest, by transfecting a cell with a first nucleic acid that encodes said cell surface capture molecule;

(b) transfecting the cell line constructed in (a) with a second nucleic acid that encodes the protein of interest, wherein said protein of interest is secreted;

(c) detecting the protein of interest displayed on the surface of a cell of the transfected cell line produced in (b) by contacting said transfected cell line produced in (b) with a detection molecule that binds the protein of interest, wherein said contacting with said detection molecule is carried out in the presence of a blocking molecule that binds the cell surface capture molecule and prevents the binding of said secreted protein of interest to said cell surface capture molecule but that does not bind to said detection molecule;

(d) isolating the cell bearing the surface displayed protein of interest detected in step (c).

2. The method of claim 1 wherein the protein of interest is an antibody.

3. The method of claim 1 , wherein the nucleic acid that encodes the protein of interest is selected from a DNA library.

4. The method of claim 1 , wherein the cell surface capture molecule is an antibody-binding protein.

5. The method of claim 4 , wherein the antibody binding protein is an Fc receptor, an anti-immunoglobulin antibody, an anti-immunoglobulin ScFv, Protein A, Protein L, Protein C, Protein H, or a functional fragment thereof.

6. The method of claim 4 , further comprising adding a membrane anchor to an antibody-binding protein such that said antibody-binding protein remains anchored in a cell membrane, exposed to the outside of the cell, and functions as a cell surface capture molecule.

7. The method of claim 6 , wherein the membrane anchor is a transmembrane anchor or a GPI link.

8. The method of claim 1 , wherein the isolated cell in claim 1 (d) is an antibody producing cell fused to an immortalized cell.

9. The method of claim 8 , wherein the antibody producing cell is a B-cell or derivative thereof.

10. The method of claim 9 , wherein the B-cell derivative is a plasma cell, a hybridoma, a myeloma, or a recombinant cell.

11. The method of claim 1 , wherein the detection molecule comprises two molecules that bind each other and are differentially labeled.

12. A method of detecting and isolating cells that produce any secreted protein of interest, comprising:

(a) constructing a cell line transiently or stably expressing a cell surface capture molecule that binds a protein of interest, by transfecting a cell with a first nucleic acid that encodes said cell surface capture molecule;

(b) detecting a cell from (a) that expresses said cell surface capture molecule;

(c) isolating and culturing the cell detected in (b);

(d) transfecting said cell isolated in (c) with a second nucleic acid that encodes the protein of interest wherein said protein of interest is secreted;

(e) detecting the protein of interest displayed on the surface of the transfected cell produced in (d) by contacting the transfected cell produced in (d) with a detection molecule that binds the protein of interest, wherein said contacting with said detection molecule is carried out in the presence of a blocking molecule that binds the cell surface capture molecule and prevents the binding of said secreted protein of interest to said cell surface capture molecule but that does not bind to said detection molecule;

(f) isolating the cell bearing the surface displayed protein of interest detected in (e).

13. A method of detecting and isolating cells that produce a protein of interest, comprising:

(a) detecting a cell that expresses a cell surface capture molecule;

(b) isolating and culturing the cell detected in (a);

(c) transfecting said cell isolated in (b) with a nucleic acid that encodes a protein of interest wherein said protein of interest is secreted;

(d) detecting the protein of interest displayed on the surface of the transfected cell produced in (c) by contacting the transfected cell produced in (c) with a detection molecule that binds the protein of interest, wherein said contacting with said detection molecule is carried out in the presence of a blocking molecule that binds the cell surface capture molecule and prevents the binding of said secreted protein of interest to said cell surface capture molecule but that does not bind to said detection molecule; and,

(e) isolating the cell bearing the surface displayed protein of interest detected in (d).

14. The method according to claim 1 , wherein the cell transfected in (a) is an immortalized eukaryotic cell.

15. The method according to claim 14 , wherein the immortalized eukaryotic cell is selected from a monkey kidney cell (COS), a Chinese hamster ovary cell (CHO), a HeLa cell, a baby hamster kidney cell (BHK), an embryonic stem cell, a human embryonic kidney cell (HEK293), a leukocyte, and a myeloma cell.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2006
From: FANDL, JAMES P.; CHEN, GANG; STAHL, NEIL; YANCOPOULOS, GEOERGE D.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 017898/0988 →
Continuity (4)
Continuation 1109915800 · Apr 5, 2005
Division 1005027900 · Jan 16, 2002
Provisional Application 6026199900 · Jan 16, 2001
Related Publication 20060234311A1 · Oct 19, 2006